AMAR REMEDIES | GILLETTE INDIA | AMAR REMEDIES/ GILLETTE INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -0.5 | 65.3 | - | View Chart |
P/BV | x | 0.1 | 25.8 | 0.2% | View Chart |
Dividend Yield | % | 0.0 | 0.4 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
AMAR REMEDIES Jun-12 |
GILLETTE INDIA Jun-18 |
AMAR REMEDIES/ GILLETTE INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 164 | 7,197 | 2.3% | |
Low | Rs | 86 | 5,002 | 1.7% | |
Sales per share (Unadj.) | Rs | 261.6 | 514.5 | 50.8% | |
Earnings per share (Unadj.) | Rs | 17.4 | 70.3 | 24.7% | |
Cash flow per share (Unadj.) | Rs | 22.3 | 83.3 | 26.8% | |
Dividends per share (Unadj.) | Rs | 0 | 23.00 | 0.0% | |
Dividend yield (eoy) | % | 0 | 0.4 | 0.0% | |
Book value per share (Unadj.) | Rs | 100.7 | 213.0 | 47.3% | |
Shares outstanding (eoy) | m | 26.16 | 32.59 | 80.3% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 0.5 | 11.9 | 4.0% | |
Avg P/E ratio | x | 7.2 | 86.8 | 8.3% | |
P/CF ratio (eoy) | x | 5.6 | 73.3 | 7.7% | |
Price / Book Value ratio | x | 1.2 | 28.6 | 4.3% | |
Dividend payout | % | 0 | 32.7 | 0.0% | |
Avg Mkt Cap | Rs m | 3,270 | 198,775 | 1.6% | |
No. of employees | `000 | NA | 0.6 | 0.0% | |
Total wages/salary | Rs m | 163 | 1,179 | 13.8% | |
Avg. sales/employee | Rs Th | NM | 27,002.4 | - | |
Avg. wages/employee | Rs Th | NM | 1,898.7 | - | |
Avg. net profit/employee | Rs Th | NM | 3,688.4 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 6,844 | 16,769 | 40.8% | |
Other income | Rs m | 21 | 128 | 16.5% | |
Total revenues | Rs m | 6,865 | 16,896 | 40.6% | |
Gross profit | Rs m | 1,131 | 3,816 | 29.6% | |
Depreciation | Rs m | 128 | 423 | 30.3% | |
Interest | Rs m | 398 | 75 | 533.5% | |
Profit before tax | Rs m | 626 | 3,446 | 18.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | -50 | 0 | - | |
Tax | Rs m | 121 | 1,156 | 10.5% | |
Profit after tax | Rs m | 455 | 2,291 | 19.9% | |
Gross profit margin | % | 16.5 | 22.8 | 72.6% | |
Effective tax rate | % | 19.3 | 33.5 | 57.6% | |
Net profit margin | % | 6.6 | 13.7 | 48.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 4,904 | 6,742 | 72.7% | |
Current liabilities | Rs m | 3,581 | 4,794 | 74.7% | |
Net working cap to sales | % | 19.3 | 11.6 | 166.4% | |
Current ratio | x | 1.4 | 1.4 | 97.4% | |
Inventory Days | Days | 124 | 44 | 285.2% | |
Debtors Days | Days | 100 | 38 | 261.4% | |
Net fixed assets | Rs m | 1,689 | 3,048 | 55.4% | |
Share capital | Rs m | 262 | 326 | 80.4% | |
"Free" reserves | Rs m | 2,358 | 6,616 | 35.6% | |
Net worth | Rs m | 2,635 | 6,942 | 38.0% | |
Long term debt | Rs m | 507 | 0 | - | |
Total assets | Rs m | 6,862 | 12,090 | 56.8% | |
Interest coverage | x | 2.6 | 47.2 | 5.5% | |
Debt to equity ratio | x | 0.2 | 0 | - | |
Sales to assets ratio | x | 1.0 | 1.4 | 71.9% | |
Return on assets | % | 12.4 | 19.6 | 63.5% | |
Return on equity | % | 17.3 | 33.0 | 52.3% | |
Return on capital | % | 31.0 | 50.7 | 61.1% | |
Exports to sales | % | 4.0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 273 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 273 | 2,782 | 9.8% | |
Fx outflow | Rs m | 2 | 5,079 | 0.0% | |
Net fx | Rs m | 271 | -2,296 | -11.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -313 | 2,371 | -13.2% | |
From Investments | Rs m | -489 | -768 | 63.6% | |
From Financial Activity | Rs m | 769 | -392 | -195.9% | |
Net Cashflow | Rs m | -33 | 1,211 | -2.7% |
Indian Promoters | % | 25.5 | 34.9 | 73.1% | |
Foreign collaborators | % | 0.0 | 40.1 | - | |
Indian inst/Mut Fund | % | 9.2 | 0.9 | 1,022.2% | |
FIIs | % | 0.0 | 7.8 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 65.3 | 16.3 | 400.6% | |
Shareholders | 13,061 | 18,623 | 70.1% | ||
Pledged promoter(s) holding | % | 99.7 | 0.0 | - |
Compare AMAR REMEDIES With: BATA INDIA COLGATE EMAMI K.S.OILS JYOTHY LABS
Compare AMAR REMEDIES With: UNILEVER PLC. (UK) P&G (US) HYPERMARCAS (Brazil)
Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.
For the quarter ended December 2020, GILLETTE INDIA has posted a net profit of Rs 819 m (up 15.2% YoY). Sales on the other hand came in at Rs 5 bn (up 13.3% YoY). Read on for a complete analysis of GILLETTE INDIA's quarterly results.
For the quarter ended September 2020, GILLETTE INDIA has posted a net profit of Rs 953 m (up 54.3% YoY). Sales on the other hand came in at Rs 5 bn (up 11.7% YoY). Read on for a complete analysis of GILLETTE INDIA's quarterly results.
For the quarter ended June 2020, GILLETTE INDIA has posted a net profit of Rs 450 m (down 1.9% YoY). Sales on the other hand came in at Rs 4 bn (down 24.4% YoY). Read on for a complete analysis of GILLETTE INDIA's quarterly results.
For the quarter ended March 2020, GILLETTE INDIA has posted a net profit of Rs 524 m (down 40.3% YoY). Sales on the other hand came in at Rs 4 bn (down 12.7% YoY). Read on for a complete analysis of GILLETTE INDIA's quarterly results.
For the quarter ended December 2019, GILLETTE INDIA has posted a net profit of Rs 711 m (up 31.6% YoY). Sales on the other hand came in at Rs 5 bn (down 3.4% YoY). Read on for a complete analysis of GILLETTE INDIA's quarterly results.
More Views on NewsIn this video, I'll tell you why I am recommending caution in the market at this time.
A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.
In this video I'll show you exactly how I go about picking stocks for trading.
100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.
More